The belief that physical and psychological symptoms should be treated separately may be profitable for some, but it’s rarely the best way to support lasting metabolic health and true well-being.
Look deeper and you’ll see mood and anxiety disorders (chronic depression, generalized anxiety, even bipolar and schizophrenia) almost always come with physical or metabolic problems. This isn’t just chance.
‘Findings suggest that mental disorders are antecedent risk factors of certain physical diseases in early life, but also vice versa.’ (Tegethoff M, et al., 2016)
‘The most substantial associations included those between affective disorders and diseases of the digestive system…anxiety disorders and arthritis…anxiety disorders and heart diseases…mental disorders and physical diseases often co-occur in childhood.’ (Tegethoff M, et.al., 2015)
‘In…adults with MDD (major depressive disorder), we found that a single session of WBH [whole-body hyperthermia] was significantly associated with a reduction in depressive symptoms when measured 5 days after treatment.’ (Janssen CW, et al., 2016)
Despite all this, metabolic problems are still mostly treated like minor side issues instead of being recognized as deeply connected to mood disorders. This includes digestive troubles, chronic low-level inflammation, oxidative stress, blood sugar imbalances, and hypothyroidism.
The bigger problem is, we’re often taught not to think about how mental and physical symptoms connect. So most people don’t notice or understand what’s really going on.
But in reality, psychological instability is closely tied to metabolic function—and with good science, you can easily see the connection goes both ways.
I’m not saying emotions or spiritual things aren’t important—they are. But when metabolism falters, the mind feels it. And when your mental state shifts, your body shows it. Knowing this could open up new ways to treat illness.
‘Chronically high anxious arousal and inflammation increase one’s risk of developing type 2 diabetes…’ (Murdock KW, et al., 2016)
‘…increased incidence of depression in patients with diabetes can be a consequence of central insulin resistance.’ (Kleinridders A, et al., 2015)
‘…5HT [serotonin] release after stress showed a significant increase with helpless behavior…’ (Petty F, et al., 1994)
‘…significant proportion of patients with depression exhibit increased inflammation, as measured by…inflammatory cytokines and acute-phase reactants, such as C-reactive protein…’ (Felger, J., et al., 2016)
‘…we expect the exogenous administration of a single dose of 400 mg pregnenolone to reduce [and normalize] the amplitude response of the amygdala that is known to be increased in lonely individuals.’ (Cacioppo S, Cacioppo JT. 2015)
The trouble is, “official” approaches to mind and body issues often contradict themselves, fueled by entrenched beliefs that make it hard to see the straightforwardness of healthy metabolic function. These old habits and ways of thinking get in the way of simple, logical solutions that could actually make a difference.
There’s really little reason to think that treating physical symptoms should make psychological symptoms worse—or the other way around. In fact, the idea that better outcomes come from treating both together is much more reasonable, and well-supported by real-world results
‘Examination of metabolic disorders in treatment-refractory depression identified an unexpectedly large proportion of patients with potentially treatable abnormalities.’ (Pan LA, et. al., 2017)
‘When patients with depression were compared with healthy controls, depression was associated with higher oxidative stress MDA [breakdown product of PUFA] levels…’ (Jiménez-Fernández S, et. al., 2015)
Much of what’s now considered “established” science about nutrition and treatment has been shaped by decades of industry-driven and politically influenced propaganda, with plenty of biased, poorly designed studies (and even outright manipulation and fraud) along the way.
Faulty core ideas about health and disease can be so deeply embedded that they become almost invisible. But seen or not, they still shape the decisions made and the results that follow. Sadly, unless these false assumptions are exposed, people rarely realize how much they’ve influenced things.
‘Increased caloric intake since 1970…not due to added sugars (including HFCS)…rather…due to increased consumption of all caloric nutrients,especially fats and flour and cereals…’ (White JS., 2013)
‘One of the most nutritionally important features of plant lectins is their ability to survive digestion by the gastrointestinal tract of consumers…they can disrupt lipid, carbohydrate and protein metabolism, promote enlargement and/or atrophy of key internal organs and tissues and alter the hormonal and immunological status…’ (Vasconcelos IM, Oliveira JT., 2004)
‘…a number of fermentable fiber supplements including pectin, corn bran, oat bran, undegraded carageenan, agar, psyllium, guar gum, and alfalfa have been shown to enhance tumor development.’ (Jacobs LR., 1986)
Common sayings like “all things in moderation,” “eat your vegetables,” or “follow a clean eating plan” sound helpful but often mislead. They usually offer little real guidance and are based on flawed or misunderstood nutrition science.
The so-called moderation rule often leads people toward calorie restriction and under-eating, while what they really need is higher-quality fuel—and more of it.
‘…dieting is ineffective because it is a stressor…Chronic stress, in addition to promoting weight gain, has been linked with a host of negative health outcomes such as atherosclerosis, coronary heart disease, hypertension, diabetes, cancer, and impaired immune functioning…’ (Tomiyama AJ, et al., 2010)
‘…lowering levels of…serotonin…reduces obesity and its complications by increasing brown adipose tissue (BAT) energy expenditure.’ (Carey AL, Kingwell BA., 2015)
The notion of just eating a balanced diet to improve health loses its impact once you look closely at the shaky scientific reasoning behind what’s considered the “right” balance of foods and portions.
‘HFCS has the same sugars composition as other “benign” fructose-glucose sweeteners such as sucrose, honey, and fruit juice concentrates and dietary sources such as fruits and juices…’ (White JS., 2008)
‘…presence of…anti-nutritional and toxic factors in food legumes…substances include proteolytic inhibitors, phytohemagglutinins, lathyrogens, cyanogenetic compounds, compounds causing favism, factors affecting digestibility and saponins…’ (Gupta YP., 1987)
‘…significant change in the Western diet, concurrent with the obesity epidemic, was a substitution of saturated fatty acids with polyunsaturated, specifically linoleic acid (LA)…The diet with 22.5% LA caused greater bodyweight gain, decreased activity, and insulin resistance compared to control and 1% LA…’ (Mamounis KJ,, 2017)
‘…sugar may provide the fuel needed to meet the energetic demands of stress, which may reduce the need for glucocorticoid-driven energy catabolism and mobilization of the body’s energy stores…’ (Tryon MS,, et. al., 2015)
High-fiber, vegetable-heavy “clean eating” isn’t really clean. It’s based on flawed science that overlooks how many raw vegetables contain anti-metabolic substances that disrupt digestion, promote stress, feed harmful bacteria, and trigger inflammation when consumed in excess.
It’s even harder to see the real damage these ideas cause because of the flood of low-quality studies that wrongly claim many stress-related biochemical substances actually improve metabolic health.
Serotonin is a perfect example. It’s often wrongly called the “happiness hormone,” suggesting that psychological problems come from having too little of it, which oversimplifies the reality.
Increasingly, research confirms what multiple studies over the years have shown: serotonin can actually promote symptoms of depression, anxiety, and mood instability.
‘…these data reveal a discrete 5-HT responsive circuit…that underlies pathological anxiety and fear associated with a hyperserotonergic state…SSRIs are currently a first-line treatment for anxiety and panic disorders but can acutely exacerbate symptoms, resulting in poor therapeutic compliance.’ (Marcinkiewcz CA,, 2016)
The idea that higher serotonin levels improve mental state makes little sense when you consider how elevated serotonin is linked to metabolic problems like digestive distress, chronic inflammation, degenerative diseases, obesity, and cancer.
Add to that the link between increased bacterial endotoxin and rising serotonin (along with other stress chemicals like nitric oxide and estrogen) in relation to digestion and mental state, and the notion that depression or anxiety is simply a low-serotonin condition doesn’t hold up.
‘More than 90% of the body’s 5-HT (serotonin) is synthesized in the gut…the microbiota promotes 5-HT biosynthesis…targeting the microbiota can serve as a tractable approach for…treating 5-HT-related disease symptoms.’ (Yano JM, et al., 2015)
‘…96 patients undergoing liver resection for malignant liver tumors…Patients with high IP5-HT [intra-platelet serotonin] levels…exhibited a reduction in morbidity, severe morbidity and LD [liver dysfunction]…patients receiving selective serotonin reuptake inhibitor treatment…displayed…an increase in postoperative morbidity…’ (Padickakudy R, et al., 2017)
‘…results suggest that endogenously released 5-HT [serotonin] activates 5-HT2A receptors to aggravate cerulein-induced pancreatitis. We propose that selective 5-HT2A antagonists may provide a new therapy for acute pancreatitis.’ (Hamada K, et al., 2007)
‘…serotonin has more recently emerged as a growth factor for human tumor cells of different origins (carcinomas, glioma and carcinoids). Several data are also available on serotonin involvement in cancer cell migration, metastatic dissemination and tumor angiogenesis…The results of several studies showed that serotonin levels in the tumor played a crucial role in cancer progression.’ (Sarrouilhe D, Mesnil M., 2019)
Though the idea that rising serotonin causes learned helplessness and mood disorders isn’t new, it hasn’t stopped the ongoing promotion and sale of profitable drugs designed to boost 5-HT levels.
There’s no solid reason to think increasing a substance that directly slows metabolism (including brain metabolism) would help psychological problems, unless you believe a “deficiency” in that substance is somehow worse. If so, you’d have to accept that suppressing metabolism is the solution, and while some argue this, I’ve never heard a convincing, logical case. Serotonin’s link to promoting brain tumors should be a clear warning by itself.
‘…increasing extracellular serotonin, SSRIs disrupt energy homeostasis and often worsen symptoms during acute treatment…symptom reduction is not achieved by the direct pharmacological properties of SSRIs, but by the brain’s compensatory responses that attempt to restore energy homeostasis. These responses take several weeks to develop, which explains why SSRIs have a therapeutic delay.’ (Andrews PW, et. al., 2015)
When drugs fail or even make symptoms tied to chronic stress and serotonin worse, those results are often ignored or dismissed as unrelated “side effects.”
‘…adverse effects studied were reported by over half the participants; most frequently Sexual Difficulties (62%) and Feeling Emotionally Numb (60%). Percentages for other effects included: Feeling Not Like Myself – 52%, Reduction In Positive Feelings – 42%, Caring Less About Others – 39%, Suicidality – 39% and Withdrawal Effects – 55%.’ (Read J, et al., 2014)
‘…use of SSRIs and more generally of antidepressants with strong inhibition of serotonin reuptake are associated with an increased risk for ICH [intracranial hemorrhage], particularly in the first 30 days of use…’ (Renoux C, et al., 2017)
‘In patients with diabetes, preadmission SSRI use was associated with increased mortality following ischaemic stroke, compared with nonuse.’ (Würtz M, et al., 2016)
Biased and inaccurate reporting of treatment results clouds the true connections between related problems. This makes it really hard to apply clear thinking and a holistic approach to tackle multiple issues at once.
‘Pregnenolone (PREG) and L-Theanine (LT) have shown ameliorative effects on various schizophrenia symptoms…blunted affect, alogia, and anhedonia…were found to be significantly improved…PREG-LT also significantly associated with a reduction of anxiety scores such as anxious mood, tension, and cardiovascular symptoms…and elevation of general functioning…’ (Kardashev A,, et al, 2018)
‘…our findings show that prostaglandin-mediated modulation of serotonergic transmission controls the affective component of inflammatory pain.’ (Singh AK, et al., 2017)
‘…rapid recovery (less than 7 days) from major depression using 125-300 mg of magnesium…with each meal and at bedtime. Magnesium was found usually effective for treatment of depression in general use. Related and accompanying mental illnesses in these case histories including traumatic brain injury, headache, suicidal ideation, anxiety, irritability, insomnia, postpartum depression, cocaine, alcohol and tobacco abuse, hypersensitivity to calcium, short-term memory loss and IQ loss were also benefited.’ (Eby GA, Eby KL., 2006)
It’s no surprise people get confused when so-called “health foods” that boost serotonin and nitric oxide (or are packed with harmful polyunsaturated fats) end up causing digestive issues and making anxiety and depression worse.
You’re more likely to believe something is helping you, even if it makes you feel sick, when there’s a big gap between how your body actually works and the popular advice about health and wellness.
Taking a broader look at the history of physiology helps reveal how symptoms are connected—something too often overlooked today when conditions get treated as if they have nothing to do with each other.
‘Cyproheptadine was effective in improving symptoms of functional abdominal pain, functional dyspepsia, in a relatively larger number of patients. Patients in smaller numbers had significant improvement 13/18 (72%) abdominal migraine, 10/10 (100%) IBS, and 6/8 (75%) cyclic vomiting syndrome. This is the first time report of improvement in IBS.’ (Madani S, et al., 2016)
‘There was a significantly stronger expression of serotonin in the prickle cells, sweat gland cells, sebaceous gland cells, and hair roots of the lesions in patients with chronic eczema. There was no positive expression of serotonin in normal skin.’ (Huang J, et al., 2004)
‘Stress and stress-induced anxiety play a major role in functional intestinal disorders…our data propose a therapeutic use of Lys [l-lysine] in the treatment of stress-related intestinal disorders, in which 5-HT sensitization and concurrent anxiety disorder are diagnosed.’ (Smriga M, Torii K., 2003)
‘…data support the hypothesis that 5-HT2B [serotonin] receptors located on endothelial cells of meningeal blood vessels trigger migraine headache through the formation of nitric oxide.’ (Schmuck K, et al., 1996)
When we talk about the biochemistry of stress honestly and with a clear, big-picture view, many overlooked or misunderstood interactions start to appear as important clues for improving metabolism. This includes how excess estrogen or serotonin relates to stress and disease, how sugar and salt intake affect mood, and the role of inflammation caused by PUFA breakdown in metabolic disorders.
‘Women are twice as likely to suffer from depression as men…instances of depression in females are associated with levels of reproductive hormones and their fluctuations across time…the change in level of estrogen is critical…exposure to the stressor…increases estrogen…evidence that a disruption in the HPA activity is associated with depression, at least in males…’ (Shors TJ, Leuner B., 2003)
‘…evidence that consumption of beverages sweetened with sugar, but not the artificial sweetener aspartame, inhibits stress-induced cortisol secretion in humans….sugar consumption…associated with greater activation of the hippocampus, which is typically inhibited during acute stress…’ (Tryon MS, et al., 2015)
‘…evidence for direct estrogenic regulation of CRF gene expression provides a compelling mechanism for sexual dimorphism of stress reactivity and prevalence of stress-related psychopathology in women…’ (Bangasser, et al., 2010)
‘Several studies have shown a positive association between depression and obesity…Selected sex hormone parameters were significantly different in overweight and obese compared to normal weight males…Depressive symptomatology was associated with increased estradiol levels in younger men, regardless of BMI.’ (Stanikova D, et al., 2018)
A clearer understanding of metabolism would naturally reveal how different factors work together, not separately.
‘…progesterone treatment decreased serum corticosterone compared to the controls and sham….results indicate that single dose progesterone may be effective for treating anxiety caused by TBI (traumatic brain injury).’ (Baykara B, et al., 2013)
Sadly, as long as industry and government are the driving forces behind what gets produced and promoted, biological principles related to nutrition and disease, showing ways to effectively approach a wide range of health problems, are unlikely to play a major role.
I’m not a doctor or scientist, and none of this is medical advice. But as long as misinformation and confusion shape what’s seen as safe or helpful, official treatments and disease prevention (whether physical or mental) are unlikely to offer solid guidance for truly improving metabolism.
‘…results strongly implicate 5-HT engagement…in acute SSRI induced aversive behaviours…and could potentially be involved in the early adverse events seen in clinical populations…’ (Marcinkiewcz CA, et al., 2016)
‘The time differential between the onset of 5HT reuptake inhibition by SSRIs (minutes) and onset of their antidepressant efficacy (weeks to months), when considered with their overall poor therapeutic effectiveness, has cast some doubt on the role of 5HT in depression…’ (Angoa-Pérez M, et al., 2014)
Many still believe that “they’re searching for a cure” and “have our best interests at heart”, but what if that’s just another product of conditioned, unexamined thought bubbles?
See more here
Add-on Pregnenolone with L-Theanine to Antipsychotic Therapy Relieves Negative and Anxiety Symptoms of Schizophrenia: An 8-week, randomized, double-blind, placebo-controlled trial.
Akhundov RA, Sultanov AA, Gadzhily RA, Sadykhov RV. Psikhoreguliruiushchaia rol’ nikotinamida [Psychoregulating role of nicotinamide]. Biull Eksp Biol Med. 1993 May;115(5):487-91. Russian.
Aksu I, Ates M, Baykara B, Kiray M, Sisman AR, Buyuk E, Baykara B, Cetinkaya C, Gumus H, Uysal N. Anxiety correlates to decreased blood and prefrontal cortex IGF-1 levels in streptozotocin induced diabetes. Neurosci Lett. 2012 Dec 7;531(2):176-81.
Andrews PW, Bharwani A, Lee KR, Fox M, Thomson JA Jr. Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response. Neurosci Biobehav Rev. 2015 Apr;51:164-88.
Angoa-Pérez M, Kane MJ, Briggs DI, Herrera-Mundo N, Sykes CE, Francescutti DM, Kuhn DM. Mice genetically depleted of brain serotonin do not display a depression-like behavioral phenotype. ACS Chem Neurosci. 2014 Oct 15;5(10):908-19.
Bangasser, D., Curtis, A., Reyes, B. et al. Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol Psychiatry 15, 896–904 (2010).
Baykara B, Aksu I, Buyuk E, Kiray M, Sisman AR, Baykara B, Dayi A, Tas A, Ozdemir D, Arda MN, Uysal N. Progesterone treatment decreases traumatic brain injury induced anxiety and is correlated with increased serum IGF-1 levels; prefrontal cortex, amygdala, hippocampus neuron density; and reduced serum corticosterone levels in immature rats. Biotech Histochem. 2013 Jul;88(5):250-7.
Bonnin A, Levitt P. Placental source for 5-HT that tunes fetal brain development. Neuropsychopharmacology. 2012 Jan;37(1):299-300.
Bridgewater, L.C., Zhang, C., Wu, Y. et al. Gender-based differences in host behavior and gut microbiota composition in response to high fat diet and stress in a mouse model. Sci Rep 7, 10776 (2017).
Cacioppo S, Cacioppo JT. Why may allopregnanolone help alleviate loneliness? Med Hypotheses. 2015 Dec;85(6):947-52.
Carey AL, Kingwell BA. Reducing peripheral serotonin turns up the heat in brown fat. Nat Med. 2015 Feb;21(2):114-6.
Chatzittofis A, Arver S, Öberg K, Hallberg J, Nordström P, Jokinen J. HPA axis dysregulation in men with hypersexual disorder. Psychoneuroendocrinology. 2016 Jan;63:247-53.
Ebrahimkhani MR, Oakley F, Murphy LB, Mann J, Moles A, Perugorria MJ, Ellis E, Lakey AF, Burt AD, Douglass A, Wright MC, White SA, Jaffré F, Maroteaux L, Mann DA. Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver disease. Nat Med. 2011 Nov 27;17(12):1668-73.
Eby GA, Eby KL. Rapid recovery from major depression using magnesium treatment. Med Hypotheses. 2006;67(2):362-70.
Feldman JM, Lee EM. Serotonin content of foods: effect on urinary excretion of 5-hydroxyindoleacetic acid. Am J Clin Nutr. 1985 Oct;42(4):639-43.
Felger, J., Li, Z., Haroon, E. et al. Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry 21, 1358–1365 (2016).
Garsed K, Chernova J, Hastings M, Lam C, Marciani L, Singh G, Henry A, Hall I, Whorwell P, Spiller R. A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea. Gut. 2014 Oct;63(10):1617-25.
Greenway SE, Pack AT, Greenway FL. Treatment of depression with cyproheptadine. Pharmacotherapy. 1995 May-Jun;15(3):357-60.
Gupta YP. Anti-nutritional and toxic factors in food legumes: a review. Plant Foods Hum Nutr. 1987;37(3):201-28.
Gupta S, Popli A, Bathurst E, Hennig L, Droney T, Keller P. Efficacy of cyproheptadine for nightmares associated with posttraumatic stress disorder. Compr Psychiatry. 1998 May-Jun;39(3):160-4.
Hamada K, Yoshida M, Isayama H, Yagi Y, Kanazashi S, Kashihara Y, Takeuchi K, Yamaguchi I. Possible involvement of endogenous 5-HT in aggravation of cerulein-induced acute pancreatitis in mice. J Pharmacol Sci. 2007 Nov;105(3):240-50.
Heisel T, Montassier E, Johnson A, Al-Ghalith G, Lin YW, Wei LN, Knights D, Gale CA. High-Fat Diet Changes Fungal Microbiomes and Interkingdom Relationships in the Murine Gut. mSphere. 2017 Oct 11;2(5):e00351-17.
Huang J, Li G, Xiang J, Yin D, Chi R. Immunohistochemical study of serotonin in lesions of chronic eczema. Int J Dermatol. 2004 Oct;43(10):723-6.
Jacobs LR. Relationship between dietary fiber and cancer: metabolic, physiologic, and cellular mechanisms. Proc Soc Exp Biol Med. 1986 Dec;183(3):299-310.
Janssen CW, Lowry CA, Mehl MR, Allen JJ, Kelly KL, Gartner DE, Medrano A, Begay TK, Rentscher K, White JJ, Fridman A, Roberts LJ, Robbins ML, Hanusch KU, Cole SP, Raison CL. Whole-Body Hyperthermia for the Treatment of Major Depressive Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2016 Aug 1;73(8):789-95.
Jiménez-Fernández S, Gurpegui M, Díaz-Atienza F, Pérez-Costillas L, Gerstenberg M, Correll CU. Oxidative stress and antioxidant parameters in patients with major depressive disorder compared to healthy controls before and after antidepressant treatment: results from a meta-analysis. J Clin Psychiatry. 2015 Dec;76(12):1658-67.
Karpinski, R. I., Kolb, A. M. K., Tetreault, N. A., & Borowski, T. B. (2018). High intelligence: A risk factor for psychological and physiological overexcitabilities. Intelligence, 66, 8–23.
Kleinridders A, Cai W, Cappellucci L, Ghazarian A, Collins WR, Vienberg SG, Pothos EN, Kahn CR. Insulin resistance in brain alters dopamine turnover and causes behavioral disorders. Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3463-8
Lee BH, Lee SW, Yoon D, Lee HJ, Yang JC, Shim SH, Kim DH, Ryu SH, Han C, Kim YK. Increased plasma nitric oxide metabolites in suicide attempters. Neuropsychobiology. 2006;53(3):127-32
Madani S, Cortes O, Thomas R. Cyproheptadine Use in Children With Functional Gastrointestinal Disorders. J Pediatr Gastroenterol Nutr. 2016 Mar;62(3):409-13.
Mamounis KJ, Yasrebi A, Roepke TA. Linoleic acid causes greater weight gain than saturated fat without hypothalamic inflammation in the male mouse. J Nutr Biochem. 2017 Feb;40:122-131.
Marcinkiewcz CA, Mazzone CM, D’Agostino G, Halladay LR, Hardaway JA, DiBerto JF, Navarro M, Burnham N, Cristiano C, Dorrier CE, Tipton GJ, Ramakrishnan C, Kozicz T, Deisseroth K, Thiele TE, McElligott ZA, Holmes A, Heisler LK, Kash TL. Serotonin engages an anxiety and fear-promoting circuit in the extended amygdala. Nature. 2016 Sep 1;537(7618):97-101.
Molero Y, Lichtenstein P, Zetterqvist J, Gumpert CH, Fazel S. Selective Serotonin Reuptake Inhibitors and Violent Crime: A Cohort Study. PLoS Med. 2015 Sep 15;12(9):e1001875.
Mudd AT, Berding K, Wang M, Donovan SM, Dilger RN. Serum cortisol mediates the relationship between fecal Ruminococcus and brain N-acetylaspartate in the young pig. Gut Microbes. 2017 Nov 2;8(6):589-600.
Murdock KW, LeRoy AS, Lacourt TE, Duke DC, Heijnen CJ, Fagundes CP. Executive functioning and diabetes: The role of anxious arousal and inflammation. Psychoneuroendocrinology. 2016 Sep;71:102-9.
Okuma H, Iijima K, Yasuda T, Tokuoka K, Kitagawa Y. Preventive effect of cyproheptadine hydrochloride in refractory patients with frequent migraine. Springerplus. 2013 Oct 29;2:573.
Ortuño, M., Robinson, S., Subramanyam, P. et al. Serotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effect. Nat Med 22, 1170–1179 (2016).
Padickakudy R, Pereyra D, Offensperger F, Jonas P, Oehlberger L, Schwarz C, Haegele S, Assinger A, Brostjan C, Gruenberger T, Starlinger P. Bivalent role of intra-platelet serotonin in liver regeneration and tumor recurrence in humans. J Hepatol. 2017 Dec;67(6):1243-1252.
Pan LA, Martin P, Zimmer T, Segreti AM, Kassiff S, McKain BW, Baca CA, Rengasamy M, Hyland K, Walano N, Steinfeld R, Hughes M, Dobrowolski SK, Pasquino M, Diler R, Perel J, Finegold DN, Peters DG, Naviaux RK, Brent DA, Vockley J. Neurometabolic Disorders: Potentially Treatable Abnormalities in Patients With Treatment-Refractory Depression and Suicidal Behavior. Am J Psychiatry. 2017 Jan 1;174(1):42-50.
Petrascheck M, Ye X, Buck LB. An antidepressant that extends lifespan in adult Caenorhabditis elegans. Nature. 2007 Nov 22;450(7169):553-6.
Petty F, Kramer G, Wilson L, Jordan S. In vivo serotonin release and learned helplessness. Psychiatry Res. 1994 Jun;52(3):285-93.
Read J, Cartwright C, Gibson K. Adverse emotional and interpersonal effects reported by 1829 New Zealanders while taking antidepressants. Psychiatry Res. 2014 Apr 30;216(1):67-73.
Renoux C, Vahey S, Dell’Aniello S, Boivin JF. Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage. JAMA Neurol. 2017 Feb 1;74(2):173-180.
Sarrouilhe D, Mesnil M. Serotonin and human cancer: A critical view. Biochimie. 2019 Jun;161:46-50.
Schmuck K, Ullmer C, Kalkman HO, Probst A, Lubbert H. Activation of meningeal 5-HT2B receptors: an early step in the generation of migraine headache? Eur J Neurosci. 1996 May;8(5):959-67.
Shors TJ, Leuner B. Estrogen-mediated effects on depression and memory formation in females. J Affect Disord. 2003 Mar;74(1):85-96.
Singh AK, Zajdel J, Mirrasekhian E, Almoosawi N, Frisch I, Klawonn AM, Jaarola M, Fritz M, Engblom D. Prostaglandin-mediated inhibition of serotonin signaling controls the affective component of inflammatory pain. J Clin Invest. 2017 Apr 3;127(4):1370-1374.
Smriga M, Torii K. L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15370-5.
Stanikova D, Luck T, Bae YJ, Thiery J, Ceglarek U, Engel C, Enzenbach C, Wirkner K, Stanik J, Kratzsch J, Riedel-Heller SG. Increased estrogen level can be associated with depression in males. Psychoneuroendocrinology. 2018 Jan;87:196-203.
Stein MB, Andrews AM. Serotonin States and Social Anxiety. JAMA Psychiatry. 2015;72(8):845–847.
Tang ZQ, Trussell LO. Serotonergic regulation of excitability of principal cells of the dorsal cochlear nucleus. J Neurosci. 2015 Mar 18;35(11):4540-51.
Tegethoff, Marion PhD; Belardi, Angelo MSc; Stalujanis, Esther BSc; Meinlschmidt, Gunther PhD. Association Between Mental Disorders and Physical Diseases in Adolescents From a Nationally Representative Cohort. Psychosomatic Medicine: April 2015 – Volume 77 – Issue 3 – p 319-332.
Tegethoff M, Stalujanis E, Belardi A, Meinlschmidt G. Chronology of Onset of Mental Disorders and Physical Diseases in Mental-Physical Comorbidity – A National Representative Survey of Adolescents. PLoS One. 2016 Oct 21;11(10):e0165196.
Tomiyama AJ, Mann T, Vinas D, Hunger JM, Dejager J, Taylor SE. Low calorie dieting increases cortisol. Psychosom Med. 2010 May;72(4):357-64.
Tryon MS, Stanhope KL, Epel ES, Mason AE, Brown R, Medici V, Havel PJ, Laugero KD. Excessive Sugar Consumption May Be a Difficult Habit to Break: A View From the Brain and Body. J Clin Endocrinol Metab. 2015 Jun;100(6):2239-47.
Vasconcelos IM, Oliveira JT. Antinutritional properties of plant lectins. Toxicon. 2004 Sep 15;44(4):385-403.
White JS. Straight talk about high-fructose corn syrup: what it is and what it ain’t. Am J Clin Nutr. 2008 Dec;88(6):1716S-1721S.
Wrubel KM, Barrett D, Shumake J, Johnson SE, Gonzalez-Lima F. Methylene blue facilitates the extinction of fear in an animal model of susceptibility to learned helplessness. Neurobiol Learn Mem. 2007 Feb;87(2):209-17.
Würtz M, Schmidt M, Grove EL, Horváth-Puhó E, Christiansen CF, Sørensen HT. Preadmission use of selective serotonin reuptake inhibitors and short-term mortality in diabetic patients hospitalized due to stroke. J Intern Med. 2016 Oct;280(4):407-18.
Yang AM, Inamine T, Hochrath K, Chen P, Wang L, Llorente C, Bluemel S, Hartmann P, Xu J, Koyama Y, Kisseleva T, Torralba MG, Moncera K, Beeri K, Chen CS, Freese K, Hellerbrand C, Lee SM, Hoffman HM, Mehal WZ, Garcia-Tsao G, Mutlu EA, Keshavarzian A, Brown GD, Ho SB, Bataller R, Stärkel P, Fouts DE, Schnabl B. Intestinal fungi contribute to development of alcoholic liver disease. J Clin Invest. 2017 Jun 30;127(7):2829-2841.
Yang Q, Yan C, Yin C, Gong Z. Serotonin Activated Hepatic Stellate Cells Contribute to Sex Disparity in Hepatocellular Carcinoma. Cell Mol Gastroenterol Hepatol. 2017 Jan 17;3(3):484-499.
Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, Nagler CR, Ismagilov RF, Mazmanian SK, Hsiao EY. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015 Apr 9;161(2):264-76.
Zeinoddini A, Ahadi M, Farokhnia M, Rezaei F, Tabrizi M, Akhondzadeh S. L-lysine as an adjunct to risperidone in patients with chronic schizophrenia: a double-blind, placebo-controlled, randomized trial. J Psychiatr Res. 2014 Dec;59:125-31.
#serotoninsorrow
#estrogeneration
#sugarsaves
#raypeat
Image: yogajournal.ru/body/practice/home-practice/ya-plakal-top-10-samykh-smeshnykh-yoga-kartinok/Jun
Copyright 2021, by Dan M @ CowsEatGrass. All rights reserved (except for quotations and images having their own protected copyrights). This copyright protects author-publisher Dan M’s right to future publication of his work in any manner, in any and all media — utilizing technology now known or hereafter devised — throughout the world in perpetuity. Everything described in this publication is for information purposes only. The author-publisher, Dan M, is not directly or indirectly presenting or recommending any part of this publication’s data as a diagnosis or prescription for any ailment of any reader. If anyone uses this information without the advice of their professional health adviser, they are prescribing for themselves, and the author- publisher assumes no responsibility or liability. Persons using any of this data do so at their own risk and must take personal responsibility for what they don’t know as well as for what they do know.